Nicholas Investment Partners, LP

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1389574 RANCHO SANTA FE, CA

Position in MIRM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$12,129,771

-$4,725,984 QoQ

Shares Held

131,303

-38.5% QoQ

Ownership

0.215%

of shares outstanding

% of Portfolio

1.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Nicholas Investment Partners, LP holds $224,688,311 across 27 Biotechnology names. MIRM ranks #7 (5.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	182,540	$29,848,940
2	RVMD	Revolution Medicines, Inc.	261,166	$25,398,393
3	BBIO	BridgeBio Pharma, Inc.	298,909	$22,196,982
4	NUVL	Nuvalent, Inc.	159,721	$16,363,416
5	XENE	Xenon Pharmaceuticals Inc.	247,101	$14,368,923
6	AXSM	Axsome Therapeutics, Inc.	81,478	$13,771,411
7	MIRM	Mirum Pharmaceuticals, Inc. This page	131,303	$12,129,771
8	APGE	Apogee Therapeutics, Inc.	130,992	$11,025,596

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,129,771	131,303	-38.5%	Shares	Sole	2026-05-15
2025-12-31	$16,855,755	213,391	-1.7%	Shares	Sole	2026-02-13
2025-09-30	$15,913,255	217,068	+17.7%	Shares	Sole	2025-11-14
2025-06-30	$9,388,339	184,483	+6.6%	Shares	Sole	2025-08-14
2025-03-31	$7,795,587	173,043	+16.3%	Shares	Sole	2025-05-15
2024-12-31	$6,154,658	148,843	+3.0%	Shares	Sole	2025-02-14
2024-09-30	$5,634,681	144,479	-4.3%	Shares	Sole	2024-11-12
2024-03-31	$3,793,170	151,002	-62.1%	Shares	Sole	2024-05-14
2023-12-31	$11,775,026	398,883	-66.7%	Shares	Sole	2024-02-08
2023-09-30	$37,899,965	1,199,366	+31.1%	Shares	Sole	2023-11-13
2023-06-30	$23,674,128	915,119	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.